Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 11, Issue 16
|
pp. 6555–6568
LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice
Back to article
Figure 1
(1 of 3)
−
100%
+
Figure 1.
Distribution of RV carriers, LAV Homozygous and WT Homozygous subjects across the groups defined by cluster analysis.
Figure 1 — LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice | Aging
